{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T08:28:57Z","timestamp":1772180937350,"version":"3.50.1"},"reference-count":6,"publisher":"Baishideng Publishing Group Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Crit Care Med"],"abstract":"<jats:p>The renin-angiotensin-aldosterone system (RAAS) undergoes profound dysregulation during septic shock, defined by persistent hypotension requiring vasopressors to maintain mean arterial pressure \u2265 65 mmHg plus lactate &gt; 2 mmol\/L, with mortality exceeding 40%. The classical RAAS pathway becomes impaired with elevated renin but paradoxically low angiotensin (Ang) II levels, correlating with poor outcomes. The alternative Ang-converting enzyme 2-Ang-(1-7)-mas receptor axis provides counter-regulatory effects but represents a \u201cdouble-edged sword\u201d in sepsis. Elevated circulating Ang-converting enzyme 2 paradoxically predicts worse outcomes, possibly through excessive Ang II depletion contributing to vasoplegia. Downstream metabolites including Ang-(1-5) and alamandine show cardioprotective properties in experimental models. Ang-(1-5) may serve as a biomarker reflecting RAAS dysregulation severity. Elevated dipeptidyl peptidase 3 exacerbates dysfunction by degrading Ang II. Experimental Ang-(1-7) infusion prevented septic shock and reduced vasopressor requirements. However, human randomized trials remain limited. Future research should focus on biomarker-guided patient stratification and multicenter trials establishing clinical utility of alternative RAAS modulation.<\/jats:p>","DOI":"10.5492\/wjccm.v15.i1.114670","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:26:41Z","timestamp":1772177201000},"source":"Crossref","is-referenced-by-count":0,"title":["Dysregulation of renin-angiotensin-aldosterone axis in septic shock: Emerging roles of angiotensin-(1-5) and alamandine"],"prefix":"10.5492","volume":"15","author":[{"given":"Arunkumaar","family":"Srinivasan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ponnsusamy","family":"Dhivya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2008.01981.x"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00023.2016"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-12-1544"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.301077"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704154"}],"container-title":["World Journal of Critical Care Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2220-3141\/full\/v15\/i1\/114670.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2220-3141\/full\/v15\/i1\/114670.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:27:05Z","timestamp":1772177225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2220-3141\/full\/v15\/i1\/114670.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":6,"journal-issue":{"issue":"1"},"alternative-id":["114670"],"URL":"https:\/\/doi.org\/10.5492\/wjccm.v15.i1.114670","relation":{},"ISSN":["2220-3141"],"issn-type":[{"value":"2220-3141","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,9]]}}}